National database for sarcoma patients in France
The "BCB-sarcomes" Database: the Database of the French Sarcoma Group Dedicated to the Collection of Clinical and Biological Data for All Sarcomas
This study is creating a national database to help doctors understand how to better treat sarcoma patients in France by tracking their care and outcomes over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150000 (estimated) |
| Sex | All |
| Sponsor | Institut Bergonié Academic / other |
| Locations | 3 sites (Bordeaux and 2 other locations) |
| Trial ID | NCT03978039 on ClinicalTrials.gov |
What this trial studies
The BCB SARCOMES database is a national clinical and biological database focused on sarcoma, comprising three main components: a pathology database for systematic review of mesenchymal tumor diagnostics, a clinical database collecting multidisciplinary tumor board data, and a longitudinal follow-up database for tracking treatment outcomes and associated samples. This initiative aims to describe patterns of care, assess treatment outcomes, and identify prognostic factors affecting patient outcomes. It is supported by the French National Cancer agency and involves collaboration among leading cancer centers in France.
Who should consider this trial
Good fit: Ideal candidates for this initiative are patients diagnosed with sarcoma who are receiving treatment in participating centers.
Not a fit: Patients with sarcoma who are not receiving treatment or are treated outside the participating centers may not benefit from this initiative.
Why it matters
Potential benefit: If successful, this initiative could enhance understanding of sarcoma treatment patterns and improve patient outcomes through better-informed clinical practices.
How similar studies have performed: Other similar initiatives have shown success in improving patient care and outcomes in oncology, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria : * Diagnosis of sarcoma * Diagnosis in a French Comprehensive Cancer Center * Any age
Where this trial is running
Bordeaux and 2 other locations
- Institut Bergonié, Comprehensive Cancer Center — Bordeaux, France (Recruiting)
- Centre Léon Bérard — Lyon, France (Recruiting)
- Institut Gustave Roussy, Comprehensive Cancer Center — Villejuif, France (Recruiting)
Study contacts
- Study coordinator: Maud Toulmonde, MD
- Email: m.toulmonde@bordeaux.unicancer.fr
- Phone: 0556333333
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.